EKOS™ Endovascular System
The EKOS™ Endovascular System is used for ultrasound-assisted, catheter-directed thrombolysis to quickly and safely dissolve pulmonary embolism (PE). Minimally invasive, EKOS™ leverages the power of targeted ultrasonic waves to thin and separate fibrin strands and accelerates lytic dispersion deeper into the clot.
EKOS™ was the first interventional device indicated for the treatment of pulmonary embolism. It is also used to treat deep vein thrombosis (DVT) and peripheral arterial occlusion (PAO).
Product Description
Acoustic Pulse Thrombolysis™
- Speeds time-to-clot dissolution.
- Results in quality clinical outcomes.
- Increases clot removal and enhances clinical improvement compared to either standard catheter-directed drug therapy or thrombectomy.1,2
- Requires significantly shorter treatment times compared to standard CDT.3
Targets the Thrombus Safely
- Lowers the risk of bleeding and other complications.3,4
- Dissolves clots without damaging vessels, valves or walls.3
More Effective Drug Delivery
- Reduces dosage requirements by as much as 68% compared to standard, catheter-directed drug therapy.3
- Requires up to 4x less drug dosage than traditional systemic delivery.5
- Reduces RV/LV ratio with as little as 8mg total tPA used in combination with EKOS™ therapy.6
Superior Clot Clearance2,3
- 48% greater drug absorption within 1 hour.1
- 84% greater drug absorption within 2 hours. 1